Share this
Arlo to Partner with Verisure
Castle Biosciences $74 Million IPO
Equillium – $65.4 Million IPO
Dot Hill Systems sale to Seagate Technology
Cooley Advises Xencor on its Initial Public Offering
Ambit Biosciences to be Acquired by Daiichi Sankyo for $410 Million
Vital Therapies Initial Public Offering
Cooley Advises Underwriters on Vital Therapies IPO
Flexion $74 Million Initial Public Offering
Cooley Advised Flexion on Initial Public Offering
Xencor Initial Public Offering
Ambit Initial Public Offering
Receptos, Inc. Initial Public Offering
Cooley Advises Ambit on its IPO
Suneva Medical Financing
Bionano Genomics Initial Public Offering
Mirati – $1.0 Billion Follow-On Offering